By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

The latest health news covers FDA's extended review of KalVista's drug, UroGen's new bladder cancer treatment approval, ...

Vietnam is willing to license AstraZeneca immediately to build vaccine and pharmaceutical factories, said Prime Minister Pham ...

In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date.